Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter the public lexicon as a new public benefit company. After a prior bankruptcy settlement was nixed by the ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Harris was on the campaign trail unveiling new playground equipment at a school in his Wicklow constituency, which had been funded by the Danish pharma company. In a November 28th letter following ...

CDMO facilities are also equipped with highly specialized equipment and facilities that prevent companies from making large capital investments in developing this infrastructure. By serving as ...

Emily Field, head of European pharma equity research at Barclays, told Reuters that until very recently she thought tariffs on prescription drugs were not a serious threat. Now she is "getting ...

Pfizer PFE0.80%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

I don't think big mergers are likely in the imminent future. How do you view the overall pharma business scenario? The branded generics business grows slower than the commodity business, but it lasts ...

My wife and I would both be dead, but for what many derisively call “Big Pharma.” My wife has a rare, genetic form of stage four lung cancer for which there is no cure. Her lungs are filled ...